A detailed history of Cidel Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Cidel Asset Management Inc holds 15,898 shares of JNJ stock, worth $2.48 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
15,898
Previous 16,429 3.23%
Holding current value
$2.48 Million
Previous $2.4 Million 7.29%
% of portfolio
0.2%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$145.48 - $167.38 $77,249 - $88,878
-531 Reduced 3.23%
15,898 $2.58 Million
Q2 2024

Jul 19, 2024

BUY
$144.38 - $157.78 $93,847 - $102,557
650 Added 4.12%
16,429 $2.4 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $181,607 - $190,405
-1,170 Reduced 6.9%
15,779 $2.5 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $1.56 Million - $1.7 Million
10,710 Added 171.66%
16,949 $2.66 Million
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $25.3 Million - $28.3 Million
-162,463 Reduced 96.3%
6,239 $971,000
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $1.9 Million - $2.05 Million
12,325 Added 7.88%
168,702 $27.9 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $68,576 - $81,838
454 Added 0.29%
156,377 $24.2 Million
Q4 2022

Feb 06, 2023

BUY
$160.2 - $179.79 $184,710 - $207,297
1,153 Added 0.74%
155,923 $27.5 Million
Q3 2022

Nov 03, 2022

SELL
$161.33 - $179.52 $4.26 Million - $4.74 Million
-26,418 Reduced 14.58%
154,770 $25.3 Million
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $609,856 - $674,472
3,626 Added 2.04%
181,188 $32.2 Million
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $539,257 - $612,401
-3,410 Reduced 1.88%
177,562 $31.5 Million
Q4 2021

Feb 08, 2022

SELL
$155.93 - $173.01 $2.62 Million - $2.91 Million
-16,800 Reduced 8.49%
180,972 $31 Million
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $26,324 - $29,253
-163 Reduced 0.08%
197,772 $31.9 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $2.3 Million - $2.47 Million
14,453 Added 7.88%
197,935 $32.6 Million
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $11 Million - $12.3 Million
72,088 Added 64.71%
183,482 $30.2 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $8.75 Million - $10 Million
-63,835 Reduced 36.43%
111,394 $17.5 Million
Q3 2020

Nov 09, 2020

SELL
$140.38 - $153.83 $125,218 - $137,216
-892 Reduced 0.51%
175,229 $26.1 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $4.23 Million - $5.11 Million
-32,873 Reduced 15.73%
176,121 $24.8 Million
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $525,247 - $727,756
-4,726 Reduced 2.21%
208,994 $27.4 Million
Q4 2019

Feb 18, 2020

BUY
$127.5 - $146.44 $12.2 Million - $14 Million
95,789 Added 81.22%
213,720 $31.2 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $11.8 Million - $13.5 Million
-92,185 Reduced 43.87%
117,931 $17.2 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $155,132 - $173,695
1,222 Added 0.58%
210,116 $27.2 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $21 Million - $23.1 Million
160,023 Added 327.44%
208,894 $29.1 Million
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $20.6 Million - $22.7 Million
-157,037 Reduced 76.27%
48,871 $29.1 Million
Q1 2019

May 06, 2019

BUY
$125.72 - $139.79 $940,008 - $1.05 Million
7,477 Added 3.77%
205,908 $28.8 Million
Q4 2018

Feb 08, 2019

BUY
$122.84 - $147.84 $3.1 Million - $3.73 Million
25,261 Added 14.59%
198,431 $25.6 Million
Q3 2018

Nov 07, 2018

SELL
$121.58 - $142.88 $2.3 Million - $2.71 Million
-18,941 Reduced 9.86%
173,170 $24 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $1.5 Million - $1.65 Million
12,553 Added 6.99%
192,111 $23.3 Million
Q1 2018

May 10, 2018

SELL
$125.1 - $148.14 $576,836 - $683,073
-4,611 Reduced 2.5%
179,558 $28.7 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $34,379 - $37,628
-262 Reduced 0.14%
184,169 $25.7 Million
Q3 2017

Oct 31, 2017

BUY
$129.47 - $135.38 $23.9 Million - $25 Million
184,431
184,431 $24 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.